Strengths and limitations
ADVANCED CANCER
Consent to access MBS and PBS data was granted by just under a third of study participants and findings may not reflect treatment patterns in the entire study cohort. However, unlike healthcare resource utilisation data collected using other means such as surveys, Medicare and PBS data are not prone to recall bias and typically provide greater accuracy than other methods of measuring costs [Despite these caveats, this analysis provides valuable insights into government funded out-of-hospital costs associated with advanced cancer pain to inform priority setting and policy development.